Does MEDVi Have Membership Fees? MEDVi vs PlexusDx (2026)

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

Full head-to-head: PlexusDx vs MEDVi →

If you’re trying to figure out whether MEDVi charges a separate membership fee on top of medication, the short answer is: it depends which path you choose. MEDVi’s compounded semaglutide and tirzepatide plans are sold as a single bundled monthly price — medication, provider visit, shipping, and ongoing support included — while MEDVi’s branded Wegovy and Zepbound paths add a separate monthly membership fee on top of the medication cost. That distinction matters because the same provider page uses the word “membership” in two different ways, which is why review sites contradict each other. This guide reconciles MEDVi’s actual fee structure, explains how the recurring subscription billing works, and shows where PlexusDx Weight Management Protocols sit relative to MEDVi — specifically Microdose GLP-1 Protocol at $129/mo flat, Semaglutide Injection at $189/mo, and Tirzepatide Injection at $289/mo. PlexusDx is cash-pay with no membership fee on any protocol.

Does MEDVi have a membership fee? The clean answer

MEDVi runs as a recurring subscription, but whether you see a separate “membership” line on your invoice depends on the medication path. On the compounded semaglutide and tirzepatide plans, the monthly price shown on MEDVi’s GLP pricing page is bundled — physician review, care plan, prescription, the compounded vial, and shipping all sit inside one charge. MEDVi states this program carries “no membership or hidden fees.” There is no second line item labeled “membership.” On the branded Wegovy and Zepbound paths, MEDVi adds a monthly membership charge separate from the medication cost. The medication itself is then dispensed at branded pricing through a partner pharmacy. Both paths are recurring subscriptions that auto-renew until cancelled, which is why MEDVi’s cancellation policy describes the program as a “Subscription Service” even when no separate membership line appears on the bill. Compare that to PlexusDx Semaglutide Injection or Tirzepatide Injection, where the listed monthly price is the full cash-pay total: no membership fee, no platform fee, and a straightforward monthly billing cycle.

What MEDVi’s compounded plans actually cost

MEDVi’s current GLP page lists compounded semaglutide injection at $299/month ongoing, with the price including physician review, personalized care plan, guidance, metabolic report, and prescription medication shipped to your door. MEDVi’s terms note the final charge may fluctuate based on the prescribed medication and the chosen pharmacy. That bundled structure makes the headline number easy to compare against PlexusDx: Semaglutide Injection on PlexusDx runs $189/mo across five dose levels (0.25mg to 2.0mg weekly), well below MEDVi’s $299 month-to-month rate. Tirzepatide Injection on PlexusDx runs $289/mo across six dose levels (2.5mg to 15mg weekly). For patients prioritizing the lowest-cost compounded option, the Microdose GLP-1 Protocol at $129/mo flat sits below every MEDVi tier and offers four delivery formats (capsule, troche, lozenge, sublingual) for needle-averse patients. None of the PlexusDx prices include a membership fee or platform charge.

What MEDVi’s branded path costs — where the membership fee lives

The membership fee that confuses readers applies specifically to MEDVi’s branded routes — Wegovy pill, Wegovy injection, and Zepbound injection. On those paths, that membership covers the platform, provider access, and ongoing care; the medication is billed separately at its branded price, which varies by product, dose, and insurance coverage. For patients with insurance that reliably covers branded GLP-1 therapy at a low copay, the membership-plus-copay path can be the cheapest overall. For patients without that coverage, branded Wegovy or Zepbound list pricing runs well above compounded therapy. PlexusDx does not dispense Wegovy or Zepbound — PlexusDx Weight Management Protocols use compounded semaglutide and tirzepatide. If your goal is the FDA-approved finished product, MEDVi’s branded path or a direct manufacturer program is the route. If your goal is cash-pay compounded therapy at a flat monthly price with no membership add-on, compare PlexusDx Semaglutide Injection, Tirzepatide Injection, and GLP-Squared against MEDVi’s compounded tier directly.

Recurring billing, cancellation, and refunds

MEDVi runs as a recurring monthly subscription that auto-renews until you cancel. Cancellation requires at least 72 hours’ notice before the next billing date, and ordinary cancellations after medication has been ordered generally do not trigger a refund. When budgeting, plan around the $299/month compounded semaglutide rate (or $399/month for tirzepatide). PlexusDx Weight Management Protocols bill monthly — 12 charges per year — with no membership tier and no separate platform fee. On the lowest-cost Microdose GLP-1 Protocol, 12 months at $129/mo is $1,548/year. On Semaglutide Injection, 12 months at $189 is $2,268/year. On Tirzepatide Injection, 12 months at $289 is $3,468/year. The billing-cycle difference alone makes the cost comparison less obvious than the headline numbers suggest.

Compounded vs branded — what each path actually dispenses

Both MEDVi’s compounded plans and PlexusDx Weight Management Protocols dispense compounded semaglutide and tirzepatide prepared by licensed U.S. compounding pharmacies. Compounded semaglutide and tirzepatide are not FDA-approved finished drug products — they are pharmacy-prepared versions of the same active ingredients found in Wegovy, Ozempic, Mounjaro, and Zepbound. MEDVi’s branded path dispenses the FDA-approved finished products themselves, the same medications that ran the SUSTAIN, STEP, and SURMOUNT clinical trials. The boxed warning for thyroid C-cell tumors applies to both semaglutide and tirzepatide based on rodent studies, regardless of whether the product is compounded or FDA-approved branded. PlexusDx differentiates on two axes neither MEDVi tier addresses: a four-format delivery menu (weekly injection, daily oral tablet, microdose troche/capsule/lozenge/sublingual, and dual-compound stacks via GLP-Squared) and an optional Precision Peptide Genetic Test that anchors dose selection to the patient’s FTO, MC4R, TCF7L2, and GIPR rs1800437 variants before titration begins.

Auto-renewal, cancellation, and refunds — what to verify before signing up

Three operational details cause most MEDVi billing surprises and apply to every cash-pay subscription model worth comparing. First, the renewal cadence: MEDVi auto-renews on a recurring basis until cancelled. Confirm the renewal cadence before enrolling so the “per month” price translates correctly into your annual cost. Second, the cancellation window: MEDVi requires at least 72 hours’ notice before the next billing date, with cancellation through the patient portal chat or by emailing hello@medvi.org. Cancel earlier than that or you’ll be charged for the next cycle. Third, refund policy: MEDVi generally does not refund once medication has been ordered, with medical disqualification as the main documented exception. PlexusDx is also cash-pay with no membership tier; review the protocol page for billing cadence and cancellation specifics before enrolling. The Precision Peptide Genetic Test is a one-time $298 purchase.

Annualized cost head-to-head — MEDVi compounded vs PlexusDx

For a cash-pay patient with no GLP-1 insurance coverage, the compounded paths line up like this. MEDVi compounded semaglutide injection: $299/month ongoing, or $299 × 12 = $3,588/year. PlexusDx Microdose GLP-1 Protocol: $129 × 12 = $1,548/year. PlexusDx Semaglutide Injection: $189 × 12 = $2,268/year. PlexusDx Tirzepatide Injection: $289 × 12 = $3,468/year. PlexusDx GLP-Squared dual-compound: $289 × 12 = $3,468/year. Add the optional Precision Peptide Genetic Test for $298. The lowest-cost direct comparison — Microdose GLP-1 Protocol at $1,548/year vs MEDVi compounded at $3,588/year ($299 × 12) — is a difference of roughly $2,040/year for cash-pay patients prioritizing total spend.

Why PlexusDx adds a genetic baseline neither tier of MEDVi includes

GLP-1 response varies meaningfully across patients. Variants in FTO (appetite regulation), MC4R (satiety signaling), and TCF7L2 (insulin response) are associated with measurably different response patterns to semaglutide and tirzepatide; GIPR rs1800437 is the headline variant for differential GLP-1 response. The Precision Peptide Genetic Test maps 49 genes and 58 variants across 14 health pathways — including 34 weight-management insights — so the prescribing clinician can see whether a faster titration, a slower titration, or a tirzepatide-first approach is more likely to fit your biology before the first dose. Neither MEDVi’s compounded plans nor MEDVi’s branded path performs this step; both rely on a population-average titration schedule adjusted by subjective tolerability over the first 8–12 weeks. PlexusDx anchors that same conversation to a measurable genetic baseline, available for $298.

Frequently Asked Questions

Does MEDVi charge a separate monthly membership fee?

Not on the compounded GLP-1 plans — MEDVi’s GLP page shows compounded semaglutide and tirzepatide as bundled pricing with medication, provider review, and shipping included in one monthly charge. On the branded Wegovy and Zepbound paths, MEDVi adds a separate monthly membership fee on top of the medication cost. PlexusDx Weight Management Protocols have no membership fee on any of the six protocols.

Is MEDVi’s $299 monthly price the total amount charged?

The ongoing compounded semaglutide rate is $299/month. MEDVi’s page states its program includes physician review, personalized care plan, guidance, metabolic report, and prescription medication shipped to your door, and its terms note the final charge may fluctuate based on medication and pharmacy, so confirm the exact total at checkout.

How much does MEDVi cost per month?

MEDVi’s semaglutide FAQ states refills are $299/month for compounded semaglutide injections. By comparison, PlexusDx Semaglutide Injection is $189/mo across five dose levels with no introductory discount and no price step-up after month one.

How often does MEDVi bill?

MEDVi runs as a recurring monthly subscription that auto-renews until you cancel. Cancel at least 72 hours before your next billing date to avoid being charged for the following month.

Can you cancel MEDVi anytime?

Yes — MEDVi runs month-to-month with no contract and no cancellation fee, but you must cancel through the patient portal chat or by emailing hello@medvi.org at least 72 hours before your next billing date to avoid being charged for the next cycle.

Does MEDVi take insurance for compounded GLP-1?

MEDVi’s compounded medications are cash-pay; insurance reimbursement may be possible for some branded options, and HSA and FSA payments are accepted at checkout. PlexusDx is also cash-pay across all six Weight Management Protocols and accepts HSA and FSA payments where eligible.

What does PlexusDx charge for compounded GLP-1 compared to MEDVi?

PlexusDx Weight Management Protocols are flat-priced with no membership fee: Microdose GLP-1 Protocol $129/mo, Semaglutide Injection $189/mo, Tirzepatide Injection $289/mo, and GLP-Squared $289/mo. The Microdose tier is below every MEDVi tier on annualized cost.

Related reading on PlexusDx

Related reading on PlexusDx: GLP-1 Cost, Semaglutide Cost, Tirzepatide Costs, Cheapest GLP-1.

Disclaimer: This article is educational and is not medical advice. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols. Pricing for MEDVi is based on the provider’s published rates as of April 2026; actual costs may vary by state, plan, and individual eligibility. PlexusDx does not sell, prescribe, or recommend any therapeutic peptide outside the GLP-1 category covered by its protocols. Discuss any GLP-1 medication decision with a licensed clinician.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.